| NCT ID | NCT07294053 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of North Carolina, Chapel Hill |
| Condition | Health Behavior |
| Study Type | INTERVENTIONAL |
| Enrollment | 543 participants |
| Start Date | 2026-02-16 |
| Primary Completion | 2028-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 543 participants in total. It began in 2026-02-16 with a primary completion date of 2028-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to examine the effects of added sugar warning labels on sugary drinks. Participants will be assigned to view either added sugar warning labels or control labels, applied on sugary drinks in an experimental store. Participants will shop for beverages in the store and take a computer survey at 4 visits spaced approximately 1 week apart.
Eligibility Criteria
Inclusion Criteria: * 18 years and older * Bought sugary drinks from a store at least once during the past week * Willing to attend 4 in-person study appointments Exclusion Criteria: * Living in the same household as someone else in the study
Contact & Investigator
Marissa Hall, PhD
PRINCIPAL INVESTIGATOR
University of North Carolina, Chapel Hill
Frequently Asked Questions
Who can join the NCT07294053 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Health Behavior. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07294053 currently recruiting?
Yes, NCT07294053 is actively recruiting participants. Contact the research team at grocerystudy@unc.edu for enrollment information.
Where is the NCT07294053 trial being conducted?
This trial is being conducted at Chapel Hill, United States.
Who is sponsoring the NCT07294053 clinical trial?
NCT07294053 is sponsored by University of North Carolina, Chapel Hill. The principal investigator is Marissa Hall, PhD at University of North Carolina, Chapel Hill. The trial plans to enroll 543 participants.